Recent insights into the mode of action of memantine and ketamine

Current Opinion in Pharmacology

Volumn 20, Issue , 2015, Pages 54-63

  Johnson, Jon W ^a   Glasgow, Nathan G ^a   Povysheva, Nadezhda V ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; GLUTAMATE DECARBOXYLASE 67; KETAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PARVALBUMIN; AMINO ACID RECEPTOR BLOCKING AGENT;

ANTIDEPRESSANT ACTIVITY; ARTICLE; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG ELIMINATION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; HEXOSE TRANSPORT; HUMAN; LOCOMOTION; MEMORY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DRUG DESIGN; MOLECULARLY TARGETED THERAPY;

ANIMALS; DRUG DESIGN; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; KETAMINE; MEMANTINE; MOLECULAR TARGETED THERAPY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84914163515     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2014.11.006     Document Type: Review

References (136)

1. D.J. Gladstone, S.E. Black, A.M. Hakim, and Heart, Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions Stroke 33 2002 2123 2136
2. K.W. Muir Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists Curr Opin Pharmacol 6 2006 53 60
3. S.F. Traynelis, L.P. Wollmuth, C.J. McBain, F.S. Menniti, K.M. Vance, K.K. Ogden, K.B. Hansen, H. Yuan, S.J. Myers, and R. Dingledine Glutamate receptor ion channels: structure, regulation, and function Pharmacol Rev 62 2010 405 496
4. P. Paoletti, C. Bellone, and Q. Zhou NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease Nat Rev Neurosci 14 2013 383 400
5. A. Lau, and M. Tymianski Glutamate receptors, neurotoxicity and neurodegeneration Pflugers Archiv: Eur J Physiol 460 2010 525 542
6. E.T. Kavalali, and L.M. Monteggia Synaptic mechanisms underlying rapid antidepressant action of ketamine Am J Psychiatry 169 2012 1150 1156
7. Q. Zhou, and M. Sheng NMDA receptors in nervous system diseases Neuropharmacology 74 2013 69 75
8. N.G. Glasgow, B.S. Retchless, and J.W. Johnson Molecular bases of NMDA receptor subtype-dependent properties J Physiol 2014
9. J.W. Johnson, and S.E. Kotermanski Mechanism of action of memantine Curr Opin Pharmacol 6 2006 61 67
10. C.G. Parsons, A. Stoffler, and W. Danysz Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse Neuropharmacology 53 2007 699 723
11. G. Rammes, W. Danysz, and C.G. Parsons Pharmacodynamics of memantine: an update Curr Neuropharmacol 6 2008 55 78
12. J. Frohlich, and J.D. Van Horn Reviewing the ketamine model for schizophrenia J Psychopharmacol 28 2014 287 302
13. T. Yamakura, K. Sakimura, and K. Shimoji The stereoselective effects of ketamine isomers on heteromeric N-methyl-d-aspartate receptor channels Anesth Analg 91 2000 225 229
14. S.M. Dravid, K. Erreger, H. Yuan, K. Nicholson, P. Le, P. Lyuboslavsky, A. Almonte, E. Murray, C. Mosely, J. Barber, and A. French Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block J Physiol 581 2007 107 128
15. K.E. Gilling, C. Jatzke, M. Hechenberger, and C.G. Parsons Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-d-aspartate (NMDA) channel blocker memantine at human nmda (GluN1/GluN2A) receptors Neuropharmacology 56 2009 866 875
16. 2+ imparts NMDA receptor subtype selectivity to the alzheimer's drug memantine J Neurosci 29 2009 2774 2779
17. 2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs Neuropharmacology 60 2011 388 396
18. M.V. Nikolaev, L.G. Magazanik, and D.B. Tikhonov Influence of external magnesium ions on the NMDA receptor channel block by different types of organic cations Neuropharmacology 62 2012 2078 2085
19. J.T. Gass, and M.F. Olive Glutamatergic substrates of drug addiction and alcoholism Biochem Pharmacol 75 2008 218 265
20. B. Winblad, S. Gauthier, D. Astrom, and K. Stender Memantine benefits functional abilities in moderate to severe Alzheimer's disease J Nutr Health Aging 14 2010 770 774
21. D. Wilkinson A review of the effects of memantine on clinical progression in Alzheimer's disease Int J Geriatr Psychiatry 27 2012 769 776
22. J.H. Krystal, D.C. D'Souza, D. Mathalon, E. Perry, A. Belger, and R. Hoffman NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development Psychopharmacology (Berl) 169 2003 215 233
23. O. Corazza, S. Assi, and F. Schifano From "special k" to "special m": The evolution of the recreational use of ketamine and methoxetamine CNS Neurosci Ther 19 2013 454 460
24. J.H. Krystal, G. Sanacora, and R.S. Duman Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond Biol Psychiatry 73 2013 1133 1141
25. E.E. Prommer Ketamine for pain: an update of uses in palliative care J Palliat Med 15 2012 474 483
26. J. Persson Ketamine in pain management CNS Neurosci Ther 19 2013 396 402
27. A. Pringle, E. Parsons, L.G. Cowen, S.F. McTavish, P.J. Cowen, and C.J. Harmer Using an experimental medicine model to understand the antidepressant potential of the N-methyl-d-aspartic acid (NMDA) receptor antagonist memantine J Psychopharmacol 26 2012 1417 1423
28. G. Sani, G. Serra, G.D. Kotzalidis, S. Romano, S.M. Tamorri, G. Manfredi, M. Caloro, C.L. Telesforo, S.S. Caltagirone, I. Panaccione, and A. Simonetti The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence CNS Drugs 26 2012 663 690
29. M.J. Alviar, T. Hale, and M. Dungca Pharmacologic interventions for treating phantom limb pain Cochrane Database Syst Rev 12 2011 CD006380
30. V. Bubenikova-Valesova, J. Horacek, M. Vrajova, and C. Hoschl Models of schizophrenia in humans and animals based on inhibition of NMDA receptors Neurosci Biobehav Rev 32 2008 1014 1023
31. B. Moghaddam, and J.H. Krystal Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans Schizophrenia Bull 38 2012 942 949
32. C. Creeley, D.F. Wozniak, J. Labruyere, G.T. Taylor, and J.W. Olney Low doses of memantine disrupt memory in adult rats J Neurosci 26 2006 3923 3932
33. E. Koros, H. Rosenbrock, G. Birk, C. Weiss, and F. Sams-Dodd The selective mGlu5 receptor antagonist mtep, similar to NMDA receptor antagonists, induces social isolation in rats Neuropsychopharmacology 32 2007 562 576
34. L. More, A. Gravius, J. Nagel, B. Valastro, S. Greco, and W. Danysz Therapeutically relevant plasma concentrations of memantine produce significant l-N-methyl-d-aspartate receptor occupation and do not impair learning in rats Behav Pharmacol 19 2008 724 734
35. J.W. Smith, F. Gastambide, G. Gilmour, S. Dix, J. Foss, K. Lloyd, N. Malik, and M. Tricklebank A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory Psychopharmacology 217 2011 255 269
36. S.E. Kotermanski, J.W. Johnson, and E. Thiels Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats Pharmacol Biochem Behav 109 2013 67 76
37. P. Cottone, A. Iemolo, A.R. Narayan, J. Kwak, D. Momaney, and V. Sabino The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats Psychopharmacology (Berl) 226 2013 127 138
38. L.E. Wise, and A.H. Lichtman The uncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist memantine prolongs spatial memory in a rat delayed radial-arm maze memory task Eur J Pharmacol 575 2007 98 102
39. C.M. Yuede, H. Dong, and J.G. Csernansky Anti-dementia drugs and hippocampal-dependent memory in rodents Behav Pharmacol 18 2007 347 363
40. P.R. Zoladz, A.M. Campbell, C.R. Park, D. Schaefer, W. Danysz, and D.M. Diamond Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane Pharmacol Biochem Behav 85 2006 298 306
41. V. Sabino, A.R. Narayan, T. Zeric, L. Steardo, and P. Cottone mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats Behav Brain Res 247 2013 9 16
42. E.L. Newman, A. Chu, B. Bahamon, A. Takahashi, J.F. Debold, and K.A. Miczek NMDA receptor antagonism: escalation of aggressive behavior in alcohol-drinking mice Psychopharmacology (Berl) 224 2012 167 177
43. E.S. Gideons, E.T. Kavalali, and L.M. Monteggia Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses Proc Natl Acad Sci U S A 111 2014 8649 8654
44. K.A. Grant, G. Colombo, J. Grant, and M.A. Rogawski Dizocilpine-like discriminative stimulus effects of low-affinity uncompetitive NMDA antagonists Neuropharmacology 35 1996 1709 1719
45. M.D. Swedberg, M. Ellgren, and P. Raboisson mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties J Pharmacol Exp Ther 349 2014 155 164
46. B. Kocsis, R.E. Brown, R.W. McCarley, and M. Hajos Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits CNS Neurosci Ther 19 2013 437 447
47. Y. Zhang, T. Yoshida, D.B. Katz, and J.E. Lisman NMDAR antagonist action in thalamus imposes delta oscillations on the hippocampus J Neurophysiol 107 2012 3181 3189
48. T. Hiyoshi, D. Kambe, J. Karasawa, and S. Chaki Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms Neuropharmacology 85 2014 384 396
49. S. Dedeurwaerdere, C. Wintmolders, R. Straetemans, D. Pemberton, and X. Langlois Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2/3 receptor agonist Psychopharmacology 214 2011 505 514
50. J.E. Lisman, J.T. Coyle, R.W. Green, D.C. Javitt, F.M. Benes, S. Heckers, and A.A. Grace Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Trends Neurosci 31 2008 234 242
51. A. Anticevic, M.W. Cole, G. Repovs, A. Savic, N.R. Driesen, G. Yang, Y.T. Cho, J.D. Murray, D.C. Glahn, X.J. Wang, and J.H. Krystal Connectivity, pharmacology, and computation: toward a mechanistic understanding of neural system dysfunction in schizophrenia Front Psychiatry 4 2013 169
52. H.P. Schmitt On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease Med Hypotheses 65 2005 259 265
53. J.W. Kinney, C.N. Davis, I. Tabarean, B. Conti, T. Bartfai, and M.M. Behrens A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons J Neurosci 26 2006 1604 1615
54. M.M. Behrens, S.S. Ali, D.N. Dao, J. Lucero, G. Shekhtman, K.L. Quick, and L.L. Dugan Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase Science 318 2007 1645 1647
55. Z. Zhou, G. Zhang, X. Li, X. Liu, N. Wang, L. Qiu, W. Liu, Z. Zuo, and J. Yang Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration Mol Neurobiol 2014
56. D.J. Lodge, M.M. Behrens, and A.A. Grace A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia J Neurosci 29 2009 2344 2354
57. V. Volman, M.M. Behrens, and T.J. Sejnowski Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity J Neurosci 31 2011 18137 18148
58. M. Martina, T. Comas, and G.A. Mealing Selective pharmacological modulation of pyramidal neurons and interneurons in the CA1 region of the rat hippocampus Front Pharmacol 4 2013 24
59. H. Monyer, N. Burnashev, D.J. Laurie, B. Sakmann, and P.H. Seeburg Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 1994 529 540
60. D.G. Standaert, G.B. Landwehrmeyer, J.A. Kerner, J.B. Penney Jr., and A.B. Young Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus Brain Res Mol Brain Res 42 1996 89 102
61. C. Volbracht, J. van Beek, C. Zhu, K. Blomgren, and M. Leist Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity Eur J Neurosci 23 2006 2611 2622
62. C. Wang, F. Liu, T.A. Patterson, M.G. Paule, and W. Slikker Jr. Preclinical assessment of ketamine CNS Neurosci Ther 19 2013 448 453
63. C.M. Emnett, L.N. Eisenman, A.M. Taylor, Y. Izumi, C.F. Zorumski, and S. Mennerick Indistinguishable synaptic pharmacodynamics of the N-methyl-d-aspartate receptor channel blockers memantine and ketamine Mol Pharmacol 84 2013 935 947
64. G. Gilmour, E.Y. Pioli, S.L. Dix, J.W. Smith, M.W. Conway, W.T. Jones, S. Loomis, R. Mason, S. Shahabi, and M.D. Tricklebank Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophrenia Psychopharmacology (Berl) 205 2009 203 216
65. B. Lord, C. Wintmolders, X. Langlois, L. Nguyen, T. Lovenberg, and P. Bonaventure Comparison of the ex vivo receptor occupancy profile of ketamine to several NMDA receptor antagonists in mouse hippocampus Eur J Pharmacol 715 2013 21 25
66. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner, G.R. Heninger, M.B. Bowers Jr., and D.S. Charney Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214
67. A. Nagels, A. Kirner-Veselinovic, R. Wiese, F.M. Paulus, T. Kircher, and S. Krach Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency Eur Arch Psychiatry Clin Neurosci 262 2012 403 414
68. A.R. Absalom, M. Lee, D.K. Menon, S.R. Sharar, T. De Smet, J. Halliday, M. Ogden, P. Corlett, G.D. Honey, and P.C. Fletcher Predictive performance of the domino, hijazi, and clements models during low-dose target-controlled ketamine infusions in healthy volunteers Br J Anaesth 98 2007 615 623
69. H.P. Hendrickson, E.C. Whaley, and S.M. Owens A validated liquid chromatographic/tandem mass spectrometric method for the determination of phencyclidine in microliter samples of rat serum J Mass Spectrom 40 2005 19 24
70. M.A. Rogawski, and G.L. Wenk The neuropharmacological basis for the use of memantine in the treatment of alzheimer's disease CNS Drug Rev 9 2003 275 308
71. 2+ entry and protein kinase C in rat cerebral cortex nerve terminals: an NMDA receptor-independent mechanism Neurochem Int 57 2010 168 176
72. J. McAllister, S. Ghosh, D. Berry, M. Park, S. Sadeghi, K.X. Wang, W.D. Parker, and R.H. Swerdlow Effects of memantine on mitochondrial function Biochem Pharmacol 75 2008 956 964
73. B. Buisson, and D. Bertrand Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor Mol Pharmacol 53 1998 555 563
74. P.D. Maskell, P. Speder, N.R. Newberry, and I. Bermudez Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-d-aspartate receptors Br J Pharmacol 140 2003 1313 1319
75. Y. Aracava, E.F. Pereira, A. Maelicke, and E.X. Albuquerque Memantine blocks alpha7∗ nicotinic acetylcholine receptors more potently than N-methyl-d-aspartate receptors in rat hippocampal neurons J Pharmacol Exp Therapeutics 312 2005 1195 1205
76. R.H. Lee, T.Y. Tseng, C.Y. Wu, P.Y. Chen, M.F. Chen, J.S. Kuo, and T.J. Lee Memantine inhibits alpha3beta2-nAChRs-mediated nitrergic neurogenic vasodilation in porcine basilar arteries PLoS One 7 2012 e40326
77. G. Rammes, R. Rupprecht, U. Ferrari, W. Zieglgansberger, and C.G. Parsons The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured hek-293 and n1e-115 cell systems in a non-competitive manner Neurosci Lett 306 2001 81 84
78. S. Kapur, and P. Seeman NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia Mol Psychiatry 7 2002 837 844
79. X. Chen, S. Shu, and D.A. Bayliss HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine J Neurosci 29 2009 600 609
80. S.A. Lipton Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond Nat Rev Drug Discov 5 2006 160 170
81. K. Nisijima, K. Kuboshima, K. Shioda, T. Yoshino, T. Iwamura, and S. Kato Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats Neurosci Lett 531 2012 198 203
82. B. Ebert, S. Mikkelsen, C. Thorkildsen, and F.M. Borgbjerg Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord Eur J Pharmacol 333 1997 99 104
83. G. Mion, and T. Villevieille Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings) CNS Neurosci Ther 19 2013 370 380
84. R.K. Paul, N.S. Singh, M. Khadeer, R. Moaddel, M. Sanghvi, C.E. Green, K. O'Loughlin, M.C. Torjman, M. Bernier, and I.W. Wainer (R,S)-ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function Anesthesiology 121 2014 149 159
85. R. Moaddel, G. Abdrakhmanova, J. Kozak, K. Jozwiak, L. Toll, L. Jimenez, A. Rosenberg, T. Tran, Y. Xiao, C.A. Zarate, and I.W. Wainer Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in alpha7 nicotinic acetylcholine receptors Eur J Pharmacol 698 2013 228 234
86. C.M. Gladding, and L.A. Raymond Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function Mol Cell Neurosci 48 2011 308 320
87. G.E. Hardingham, and H. Bading Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders Nat Rev Neurosci 11 2010 682 696
88. M.P. Parsons, and L.A. Raymond Extrasynaptic NMDA receptor involvement in central nervous system disorders Neuron 82 2014 279 293
89. K. Le Meur, M. Galante, M.C. Angulo, and E. Audinat Tonic activation of nmda receptors by ambient glutamate of non-synaptic origin in the rat hippocampus J Physiol 580 2007 373 383
90. T.M. Fleming, V. Scott, K. Naskar, N. Joe, C.H. Brown, and J.E. Stern State-dependent changes in astrocyte regulation of extrasynaptic NMDA receptor signalling in neurosecretory neurons J Physiol 589 2011 3929 3941
91. N.V. Povysheva, and J.W. Johnson Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons J Neurophysiol 107 2012 2232 2243
92. T. Papouin, L. Ladepeche, J. Ruel, S. Sacchi, M. Labasque, M. Hanini, L. Groc, L. Pollegioni, J.P. Mothet, and S.H. Oliet Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists Cell 150 2012 633 646
93. C.M. Wroge, J. Hogins, L. Eisenman, and S. Mennerick Synaptic NMDA receptors mediate hypoxic excitotoxic death J Neurosci 32 2012 6732 6742
94. X. Zhou, D. Hollern, J. Liao, E. Andrechek, and H. Wang NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors Cell Death & Disease 4 2013 e560
95. X. Zhou, Q. Ding, Z. Chen, H. Yun, and H. Wang Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-d-aspartate receptor function and neuronal excitotoxicity J Biol Chem 288 2013 24151 24159
96. F. Leveille, F. El Gaamouch, E. Gouix, M. Lecocq, D. Lobner, O. Nicole, and A. Buisson Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors FASEB J 22 2008 4258 4271
97. S. Papadia, F.X. Soriano, F. Leveille, M.A. Martel, K.A. Dakin, H.H. Hansen, A. Kaindl, M. Sifringer, J. Fowler, V. Stefovska, and G. McKenzie Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses Nat Neurosci 11 2008 476 487
98. S. Okamoto, M.A. Pouladi, M. Talantova, D. Yao, P. Xia, D.E. Ehrnhoefer, R. Zaidi, A. Clemente, M. Kaul, R.K. Graham, and D. Zhang Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin Nat Med 15 2009 1407 1413
99. P. Xia, H.S. Chen, D. Zhang, and S.A. Lipton Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses J Neurosci 30 2010 11246 11250
100. A.J. Milnerwood, C.M. Gladding, M.A. Pouladi, A.M. Kaufman, R.M. Hines, J.D. Boyd, R.W. Ko, O.C. Vasuta, R.K. Graham, M.R. Hayden, and T.H. Murphy Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in huntington's disease mice Neuron 65 2010 178 190
101. A.M. Kaufman, A.J. Milnerwood, M.D. Sepers, A. Coquinco, K. She, L. Wang, H. Lee, A.M. Craig, M. Cynader, and L.A. Raymond Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons J Neurosci 32 2012 3992 4003
102. A. Dau, C.M. Gladding, M.D. Sepers, and L.A. Raymond Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in huntington disease transgenic mice Neurobiol Dis 62 2014 533 542
103. A.R. Wild, E. Akyol, S.L. Brothwell, P. Kimkool, J.N. Skepper, A.J. Gibb, and S. Jones Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones Neuropharmacology 73 2013 138 146
104. 2+ in hippocampal slices Neuropharmacology 38 1999 1253 1259
105. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, P.F. Cheng, E.T. Kavalali, and L.M. Monteggia NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 2011 91 95
106. E. Nosyreva, K. Szabla, A.E. Autry, A.G. Ryazanov, L.M. Monteggia, and E.T. Kavalali Acute suppression of spontaneous neurotransmission drives synaptic potentiation J Neurosci 33 2013 6990 7002
107. K.R. Tovar, and G.L. Westbrook The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro J Neurosci 19 1999 4180 4188
108. F. Steigerwald, T.W. Schulz, L.T. Schenker, M.B. Kennedy, P.H. Seeburg, and G. Kohr C-terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors J Neurosci 20 2000 4573 4581
109. L. Groc, M. Heine, S.L. Cousins, F.A. Stephenson, B. Lounis, L. Cognet, and D. Choquet NMDA receptor surface mobility depends on NR2A-2B subunits Proc Natl Acad Sci U S A 103 2006 18769 18774
110. C.G. Thomas, A.J. Miller, and G.L. Westbrook Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons J Neurophysiol 95 2006 1727 1734
111. A.Z. Harris, and D.L. Pettit Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices J Physiol 584 2007 509 519
112. K.B. Hansen, K.K. Ogden, H. Yuan, and S.F. Traynelis Distinct functional and pharmacological properties of triheteromeric GluN1/GluN2A/GluN2B NMDA receptors Neuron 81 2014 1084 1096
113. A. Momiyama Distinct synaptic and extrasynaptic NMDA receptors identified in dorsal horn neurones of the adult rat spinal cord J Physiol 523 2000 621 628
114. S.G. Brickley, C. Misra, M.H. Mok, M. Mishina, and S.G. Cull-Candy NR2B and NR2D subunits coassemble in cerebellar golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites J Neurosci 23 2003 4958 4966
115. N.A. Lozovaya, S.E. Grebenyuk, T. Tsintsadze, B. Feng, D.T. Monaghan, and O.A. Krishtal Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst epsc in rat hippocampus J Physiol 558 2004 451 463
116. S.C. Harney, D.E. Jane, and R. Anwyl Extrasynaptic NR2D-containing NMDARs are recruited to the synapse during LTP of NMDAR-EPSCs J Neurosci 28 2008 11685 11694
117. H.S. Chen, J.W. Pellegrini, S.K. Aggarwal, S.Z. Lei, S. Warach, F.E. Jensen, and S.A. Lipton Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity J Neurosci 12 1992 4427 4436
118. K.E. Gilling, C. Jatzke, and C.G. Parsons Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-d-aspartate receptors by memantine Neuropharmacology 53 2007 415 420
119. T.A. Blanpied, F.A. Boeckman, E. Aizenman, and J.W. Johnson Trapping channel block of NMDA-activated responses by amantadine and memantine J Neurophysiol 77 1997 309 323
120. G.A. Mealing, T.H. Lanthorn, C.L. Murray, D.L. Small, and P. Morley Differences in degree of trapping of low-affinity uncompetitive N-methyl-d-aspartic acid receptor antagonists with similar kinetics of block J Pharmacol Exp Ther 288 1999 204 210
121. H.S.V. Chen, and S.A. Lipton Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-d-aspartate-gated channels J Pharmacol Exp Therapeutics 314 2005 961 971
122. S.E. Kotermanski, J.T. Wood, and J.W. Johnson Memantine binding to a superficial site on NMDA receptors contributes to partial trapping J Physiol 587 2009 4589 4604
123. S.M. Antonov, and J.W. Johnson Voltage-dependent interaction of open-channel blocking molecules with gating of NMDA receptors in rat cortical neurons J Physiol (Lond) 493 1996 425 445
124. A.I. Sobolevsky, S.G. Koshelev, and B.I. Khodorov Probing of NMDA channels with fast blockers J Neurosci 19 1999 10611 10626
125. T.A. Blanpied, R.J. Clarke, and J.W. Johnson Amantadine inhibits NMDA receptors by accelerating channel closure during channel block J Neurosci 25 2005 3312 3322
126. H. Yuan, K. Erreger, S.M. Dravid, and S.F. Traynelis Conserved structural and functional control of N-methyl-d-aspartate receptor gating by transmembrane domain m3 J Biol Chem 280 2005 29708 29716
127. E. Neher, and J.H. Steinbach Local anaesthetics transiently block currents through single acetylcholine-receptor channels J Physiol (Lond) 277 1978 153 176
128. M. Benveniste, and M.L. Mayer Trapping of glutamate and glycine during open channel block of rat hippocampal neuron NMDA receptors by 9-aminoacridine J Physiol 483 1995 367 384
129. J.W. Johnson, and A. Qian Interaction between channel blockers and channel gating of NMDA receptors Biol Membr 19 2002 17 22
130. E. Karakas, and H. Furukawa Crystal structure of a heterotetrameric NMDA receptor ion channel Science 344 2014 992 997
131. C.H. Lee, W. Lu, J.C. Michel, A. Goehring, J. Du, X. Song, and E. Gouaux NMDA receptor structures reveal subunit arrangement and pore architecture Nature 511 2014 191 197
132. B. Siegler Retchless, W. Gao, and J.W. Johnson A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction Nat Neurosci 15 2012 406-413 S401-402
133. J. Pan, Q. Chen, D. Willenbring, D. Mowrey, X.P. Kong, A. Cohen, C.B. Divito, Y. Xu, and P. Tang Structure of the pentameric ligand-gated ion channel glic bound with anesthetic ketamine Structure 20 2012 1463 1469
134. T. Yamakura, H. Mori, H. Masaki, K. Shimoji, and M. Mishina Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists Neuroreport 4 1993 687 690
135. K. Kashiwagi, T. Masuko, C.D. Nguyen, T. Kuno, I. Tanaka, K. Igarashi, and K. Williams Channel blockers acting at N-methyl-d-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore Mol Pharmacol 61 2002 533 545
136. W. Humphrey, A. Dalke, and K. Schulten VMD: Visual molecular dynamics J Mol Graph 14 1996 33-38, 27-38